AIM Rule 26

The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies

ValiRx plc is listed on AIM of the London Stock Exchange under the ticker code VAL. There are no restrictions on the transfer of ValiRx’s shares and these are not listed on any other exchange.

These disclosures were last reviewed on the 30-11-2020.

AIM Securities Information

ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, it’s “principal” place of business is in the United Kingdom.

The Total Number of AIM Securities in issue with nominal value of 0.1p is 64,882,490

The information below was last updated on 30 November 2020.

The percentage of AIM Securities not in public hands is approximately 19.6%.

Our majority shareholder(s)

Shareholder(s) with more than 3%

Shareholders Number of Shares Percentage of Total
Mr Nicholas Slater (TR1) 4,306,600 6.6%
Monecor (London) Ltd 4,466,969 6.9%
Mr Adam Hargreaves (TR1) 3,249,931 5.0%

The Directors’ holding

Shareholders Number of Shares Percentage of Total
Directors 732,834 1.1%

Advisors

Corporate Broker

Peterhouse Capital Limited, 80 Cheapside, London, EC2V 6EE
Email: info@peterhousecap.com
Tel: +44 (0) 20 7469 0930
www.peterhousecap.com

Nominated Adviser

Cairn Financial Advisers LLP, Cheyne House, Crown Court, 62-63 Cheapside, London, EC2V 6AX
www.cairnfin.com

Registrars

Neville Registrars Limited, Neville House, Steelpark Road, Halesowen B62 8HD
Email: info@nevilleregistrars.co.uk
Tel: +44 (0) 121585 1131
www.nevilleregistrars.co.uk

Solicitors

DACBeachcroft, 25 Walbrook, London, EC4N 8AF
www.dacbeachcroft.com/en/gb/locations/london-walbrook

Auditors

Adler Shine, Aston House, Cornwall Avenue, Finchley, N3 1LF

Bankers

The Royal Bank of Scotland, Argylle House, 246 Regent Street, London, W1B 3PB

Corporate Governance

The Board of Directors is committed to applying high standards of corporate governance using the guidance of the QCA Code, revised in April 2018 as devised by the Quoted Companies Alliance.

The Corporate Governance sets out ValiRx’s compliance with the ten principles of the QCA Code, displaying how the company complies, and provides links to appropriate disclosures.

These arrangements are also disclosed in our Annual Report and Accounts.

These disclosures were last reviewed on the 30-11-2020.